- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Face-to-face consultations
- Phone consultations
Last updated: 19 Apr 2020
- Home chemotherapy
Dr Chris Herbert qualified in medicine at Birmingham University in 2000. He trained in Clinical Oncology in Bristol and completed his oncology training as a clinical research fellow at the British Columbia Cancer Agency in Vancouver, Canada, where he specialised in stereotactic radiosurgery and the treatment of benign and malignant adult brain tumours.
Appointed as consultant Clinical Oncologist in Bristol in 2011, he has an interest in the treatment melanoma and brain tumours, both primary and secondary. He has expertise in the treatment of metastatic and high risk melanoma with immunotherapy and targeted treatments. He has trained in technical radiotherapy, specialising in the treatment of adult brain tumours, including stereotactic radiosurgery and proton therapy. He has published work on stereotactic radiosurgery and external beam radiotherapy in international, peer reviewed journals.
Areas of interest
Melanoma, primary brain tumours and brain metastases
- Becky Gordon
- Spire Oncology Centre South West 300 Park Avenue Aztec West Almondsbury Bristol BS32 4SY
- 01454 456542
Current NHS consultant posts held
Consultant Clinical Oncologist Bristol Cancer Institute
Dr herbert has acted as principal investigator on numerous clinical trials in brain tumours and malignant melanoma.
- FRCR Royal college of Radiologists 2009
- MRCP Royal College of Physicians 2004
- MBChB (Hons) University of Birmingham 2000
- BSc (Hons) University of wales 1992
Reference number 4703943
Details of entry to specialist register
- Clinical oncology, 2011
- Healthcare At Home 1-5 Whiteladies Road...
- 17:00 - 18:30
- 0117 342 3008
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.